Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteersFURLANUT, M; MONTANARI, G; PEROSA, A et al.International journal of clinical pharmacology research. 1985, Vol 5, Num 3, pp 165-170, issn 0251-1649Article

ADVERSE DRUG REACTIONS: A CONTINUING PROBLEMFELDMANN EG.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 585Article

INTERNATIONAL SYMPOSIUM ON BENOXAPROFEN. PROCEEDINGS1980; J. RHEUMATOL.; CAN; DA. 1980; VOL. 7; SUPPL. 6; 143 P.; BIBL. DISSEM.Conference Paper

Activated α-alkyl-α-arylacetic acid enantiomers for stereoselective thin-layer chromatographic and high-performance liquid chromatographic determination of chiral aminesWEBER, H; SPAHN, H; MUTSCHLER, E et al.Journal of chromatography. 1984, Vol 307, Num 1, pp 145-153, issn 0021-9673Article

BENOXAPROFEN AND PAPILLARY NECROSISERWIN L; JONES JMB.1982; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1982; VOL. 285; NO 6343; PP. 694; BIBL. 3 REF.Article

A COMPARATIVE TRIAL OF BENOXAPROFEN AND NAPROXENHIGHTON J; GRAHAME R.1978; RHEUMATOL. AND REHABILIT.; GBR; DA. 1978; VOL. 17; NO 4; PP. 259-264; BIBL. 8 REF.Article

Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin: Studies by tandem mass spectrometryQIU, Y; BURLINGAME, A. L; BENET, L. Z et al.Drug metabolism and disposition. 1998, Vol 26, Num 3, pp 246-256, issn 0090-9556Article

LE BENOXAPROFENE PERMET-IL DE PREVENIR L'ASTHME A L'ACIDE ACETYLSALICYLIQUE.TONNEL AB; FOURNIER E; WALLAERT B et al.1982; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1982; VOL. 11; NO 49; PP. 3654-3655; BIBL. 3 REF.Article

EFFECTS OF THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG BENOXAPROFEN ON LEUCOCYTE MIGRATIONMEACOCK SCR; KITCHEN EA.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 6; PP. 366-370; BIBL. 12 REF.Article

Mechanisms of drug photosensitizationKOCHEVAR, I. E.Photochemistry and photobiology. 1987, Vol 45, Num 6, pp 891-895, issn 0031-8655Article

Fatal self-poisoning with benoxaprofenFRANCOURT, G. J; ADAMS, H; WALLS, J et al.Human toxicology. 1984, Vol 3, Num 6, pp 517-519, issn 0144-5952Article

EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON HUMAN LEUCOCYTESWILDFEUER A.1983; ZEITSCHRIFT FUER RHEUMATOLOGIE; ISSN 0340-1855; DEU; DA. 1983; VOL. 42; NO 1; PP. 16-20; ABS. GER; BIBL. 12 REF.Article

Spectroscopic studies of cutaneous photosensitizing agents. IV: The photolysis of benaxoprofen, an anti-inflammatory drug with phototoxic propertiesRESZKA, K; CHIGNELL, C. F.Photochemistry and photobiology. 1983, Vol 38, Num 3, pp 281-291, issn 0031-8655Article

ASSOCIATION BETWEEN STEVENS-JOHNSON SYNDROME AND BENOXAPROFENTAYLOR AEM; GOFF D; HINDSON TC et al.1981; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1981; NO 6274; PP. 1433; BIBL. 4 REF.Article

Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesisSIROIS, P; SALARI, H; BORGEAT, P et al.Inflammation. 1984, Vol 8, Num 4, pp 353-364, issn 0360-3997Article

BENOXAPROFEN: SIDE-EFFECT PROFILE IN 300 PATIENTSHALSEY JP; CARDOE N.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6326; PP. 1365-1368; BIBL. 22 REF.Article

EFFECTS OF FENOPROFEN AND BENOXAPROFEN ON HUMAN LYMPHOCYTES: INHIBITION OF TRITIATED THYMIDINE UPTAKE.PANUSH RS.1978; AGENTS AND ACTIONS; SWITZ.; DA. 1978; VOL. 8; NO 3; PP. 238-243; BIBL. 24 REF.Article

The metabolic chiral inversion of 2-arylpropionic acids: a novel route with pharmacological consequencesHUTT, A. J; CALDWELL, J.Journal of pharmacy and pharmacology. 1983, Vol 35, Num 11, pp 693-704, issn 0022-3573Article

BENOXAPROFEN KINETICS IN RENAL IMPAIRMENTARONOFF GR; OZAWA T; DESANTE KA et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 190-194; BIBL. 11 REF.Article

A RAPID HIGH PRESSURE LIQUID CHROMATOGRAPHIC ASSAY OF BENOXAPROFEN IN PLASMAFLEITMAN JS; LEE CS; PERRIN JH et al.1980; J. LIQ. CHROMATOGR.; ISSN 0148-3919; USA; DA. 1980; VOL. 3; NO 8; PP. 1165-1172; BIBL. 6 REF.Article

PHARMACOKINETIC STUDIES WITH BENOXAPROFEN IN MAN: PREDICTION OF STEADY-STATE LEVELS FROM SINGLE-DOSE DATA.CHATFIELD DH; TARRANT ME; SMITH GL et al.1977; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1977; VOL. 4; NO 5; PP. 579-583; BIBL. 6 REF.Article

Stereoselective metabolism of benoxaprofen in rats: Biliary excretion of benoxaprofen taurine conjugate and glucuronideMOHRI, K; OKADA, K; BENET, L. Z et al.Drug metabolism and disposition. 1998, Vol 26, Num 4, pp 332-337, issn 0090-9556Article

A comparative study of the photochemistry of the non-steroidal anti-inflammatory drugs, naproxen, benoxaprofen and indomethacinMOORE, D. E; CHAPPUIS, P. P.Photochemistry and photobiology. 1988, Vol 47, Num 2, pp 173-180, issn 0031-8655Article

Comparison of the pro-oxidative interactions of flunoxaprofen and benoxaprofen with human polymorphonuclear leucocytes in vitroVAN RENSBURG, A. J; THERON, A. J; ANDERSON, R et al.Agents and actions. 1991, Vol 33, Num 3-4, pp 292-299, issn 0065-4299, 8 p.Article

Oliguric renal failure associated with benoxaprofenONWUBALILI, J. K.Nephron. 1983, Vol 35, Num 4, pp 279-280, issn 0028-2766Article